Skip to main content
Log in

2-Aryl hydrazonopropanal pharmacophores as potent cytotoxic agents against human hepatocellular carcinoma cell line

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

The versatile synthon E-methyl 2-(2-(1,3-dioxo-1-arylpropan-2-ylidene) hydrazinyl) benzoate has a potent cytotoxic activity, which was screened in vitro for anticancer activity against human hepatocellular carcinoma cell (HCC) line. The results show a higher anticancer efficacy and higher selectivity index (SI) on HCC versus doxorubicin that warrants further studies in both animals and humans; this work has been patented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Akamatsu M (2011) Importance of physicochemical properties for the design of new pesticides. J Agric Food Chem 59:2909–2917

    Article  CAS  PubMed  Google Scholar 

  • Alves RC, Alves D, Guz B et al. (2011) Advanced hepatocellular carcinoma. Review of targeted molecular drugs. Ann Hepatol 10:21–27

    Article  PubMed  Google Scholar 

  • Al-Zaydi KM, Borik RM (2007) Microwave assisted condensation reactions of 2-aryl hydrazonopropanals with nucleophilic reagents and dimethyl acetylenedicarboxylate. Molecules 12:2061–2079

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Al-Zaydi KM, Saleh TS, Bin Hadda T (2019) Potent cytotoxic agents against human hepatocellular carcinoma cell line based 2-aryl hydrazonopropanals pharmacophore. US Patent 10,280, 134B1

  • Arnott JA, Kumar R, Planey SL (2013) Lipophilicity indices for drug Development. J Appl Biopharm Pharcokin 1:31–36

    Google Scholar 

  • Arnott JA, Planey SL (2012) The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov 7:863–875

    Article  CAS  PubMed  Google Scholar 

  • Badisa RB, Darling-Reed SF, Joseph P, Cooperwood JS, Latinwo LM (2009) Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF7 cells. Anticancer Res 29:2993–2996

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bassyouni FA, Abu-Baker SM, Mahmoud K, Moharam M, El-Nakkady SS, Abdel-Rehim M (2014) Synthesis and biological evaluation of some new triazolo[1,5-a]quinoline derivatives as anticancer and antimicrobial agents. RSC Adv 4(46):24131–24141

    Article  CAS  Google Scholar 

  • Blum HE (2005) Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol 11:7391–7400

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bosch FX, Ribes J, Díaz M, Cléries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 27:5–16

    Article  Google Scholar 

  • Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631–651

    Article  CAS  PubMed  Google Scholar 

  • Chen KF, Chen HL, Tai WT, Feng WC, Hsu CH, Chen PJ, Cheng AL (2011) Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells. J Pharm Exp Ther 337:155–161

    Article  CAS  Google Scholar 

  • Curatolo W (1998) Physical chemical properties of oral drug candidates in the discovery and exploratory drug development settings. Pharm Sci Technol Today 19:387–393

    Article  Google Scholar 

  • El-Menshawi BS, Fayad W, Mahmoud K, El-Hallouty SM, El- Manawaty M, Olofsson MH, Linder S (2010) Screening of natural products for therapeutic activity against solid tumors. Indian J Exp Biol 48:258–264

    PubMed  Google Scholar 

  • Gleeson MP (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J Med Chem 51:817–834

    Article  CAS  PubMed  Google Scholar 

  • Hung CS, Lin SF, Liu HH et al. (2012) Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma. Ann Surg Oncol 19:2744–2752

    Article  PubMed  Google Scholar 

  • Kaseb AO, Shindoh J, Patt YZ et al. (2013) Modified cisplatin/interferon alpha-2b/doxorubicin/5-fluorouracil [PIAF] chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unrespectable hepatocellular carcinoma. Cancer 119:3334–3342

    Article  CAS  PubMed  Google Scholar 

  • Kearns EH, Di L (2008) Drug-like properties: concepts, structure design and methods. Elsevier, USA

    Google Scholar 

  • Kellen JA (1993) The reversal of multidrug resistance in cancer (review). Anticancer Res 13:959–961

    CAS  PubMed  Google Scholar 

  • Kodama Y, Fumoto S, Nishi J et al. (2008) Absorption and distribution characteristics of 5-fluorouracil [5-FU] after an application to the liver surface in rats in order to reduce systemic side effects. Biol Pharm Bull 31:1049–1052

    Article  CAS  PubMed  Google Scholar 

  • Li T, Dong ZR, Guo ZY et al. (2013) Aspirin enhances IFN-alpha-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway. Cancer Gene Ther 20:366–374

    Article  CAS  PubMed  Google Scholar 

  • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 46:3–26

    Article  CAS  Google Scholar 

  • Malik MA, Raza MK, Dar OA, Abid M, Wani MY, Al-Bogami AS, Hashmi AA (2019) Probing the antibacterial and anticancer potential of tryptamine based mixed ligand Schiff base Ruthenium (III) complexes. Bioorg Chem 87:773–782

    Article  CAS  PubMed  Google Scholar 

  • Masriani M, Mustofa M, Jumina J, Sunarti S, Enawaty E (2014) Cytotoxic and pro-apoptotic activities of crude alkaloid from root of sengkubak (Pynarrhena cauliflora (Miers) Diels) in human breast cancer T47D cell line. Sch Acad J Biosci 2(5):336–340

    Google Scholar 

  • Minotti G, Recalcati S, Mordente A et al. (1998) The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J 12:541–552

    Article  CAS  PubMed  Google Scholar 

  • Miyamoto Y, Koh YH, Park YS et al. (2003) Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol Chem 384:567–574

    Article  CAS  PubMed  Google Scholar 

  • Mosmann T (1983) Rapid colorimetric assays for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

    Article  CAS  PubMed  Google Scholar 

  • Rutman RJ, Cantarow A, Paschkis KE (1954) Studies in 2-acetylaminofluorene carcinogenesis. I. The intracellular distribution of nucleic acids and protein in rat liver. Cancer Res 14:111–114

    CAS  PubMed  Google Scholar 

  • Song DS, Bae SH, Song MJ et al. (2013) Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 19:4679–4688

    Article  PubMed  PubMed Central  Google Scholar 

  • Tapiero H, Mishal Z, Wioland M, Silber A, Fourcade A, Zwingelstein G (1986) Changes in biophysical parameters and in phospholipid composition associated with resistance to doxorubicin. Anticancer Res 6:649–652

    CAS  PubMed  Google Scholar 

  • Thabrew MI, Hughes RD, McFarlane IG (1997) Screening of hepatoprotective plant components using a HepG2 cell cytotoxicity assay. J Pharm Pharm 49:1132–1135

    Article  CAS  Google Scholar 

  • Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang S, Kotamraju S, Konorev E et al. (2002) Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem J 367:729–740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wani MY, Bhat AR, Azam A, Athar F (2013) Nitroimidazolyl hydrazones are better amoebicides than their cyclized 1, 3, 4-oxadiazoline analogues: in vitro studies and Lipophilic efficiency analysis. Eur J Med Chem 64:190–199

    Article  CAS  PubMed  Google Scholar 

  • Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989–5005

    Article  CAS  PubMed  Google Scholar 

  • Yang TS, Lin YC, Chen JS et al. (2014) Phase II study of gemcitabine Oncol Rev 8:246, 31

    Google Scholar 

Download references

Acknowledgements

This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (P-0140-363-0436). The authors, therefore, acknowledged with thanks DSR technical and financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Khadijah M. Alzaydi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alzaydi, K.M., Saleh, T.S. 2-Aryl hydrazonopropanal pharmacophores as potent cytotoxic agents against human hepatocellular carcinoma cell line. Med Chem Res 29, 199–205 (2020). https://doi.org/10.1007/s00044-019-02473-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-019-02473-8

Keywords

Navigation